Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Der Pathologe|May 6, 2021
[BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version]Michael Hummel, Susanna Hegewisch-Becker, Jens Neumann, et al.
Der Pathologe|July 14, 2021
BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic optionsMichael Hummel, Susanna Hegewisch-Becker, Jens H L Neumann, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2002
41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseasesDjordje Atanackovic, Axel Nierhaus, Michael Neumeier, et al.
The Oncologist|December 17, 2009
Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?Sebastian Kobold, Susanna Hegewisch-Becker, Karin Oechsle, et al.
Anti-Cancer Drugs|June 19, 2004
Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experienceGert Tuinmann, Susanna Hegewisch-Becker, Reinhart Zschaber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Characterization of effusion-infiltrating T cells: benign versus malignant effusionsDjordje Atanackovic, Andreas Block, Andreas de Weerth, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 17, 2002
Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavityChristoph Sagowski, Michael Jaehne, Wolfgang Kehrl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignanciesSusanna Hegewisch-Becker, Katharina Braun, Markus Otte, et al.
Pageof 7